Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 6/2017

01-06-2017 | Head and Neck

Relationship between response to induction chemotherapy and disease control in patients with advanced laryngeal carcinoma included in an organ preservation protocol

Authors: Xavier León, Cristina Valero, Carlota Rovira, Camilo Rodriguez, Montserrat López, Jacinto García-Lorenzo, Miquel Quer

Published in: European Archives of Oto-Rhino-Laryngology | Issue 6/2017

Login to get access

Abstract

The aim of the study is to analyze the relationship between the degree of response to induction chemotherapy and the disease control in patients with locally advanced laryngeal carcinomas candidates to total laryngectomy. This retrospective study includes 389 patients with T3–T4 laryngeal tumors candidates to total laryngectomy, diagnosed between 1985 and 2013, treated with induction chemotherapy in an organ preservation protocol. Five-year local recurrence-free survival for patients receiving conservative treatment with radiotherapy after a complete response to induction chemotherapy was 75.4%; for patients with partial response greater than 50%, it was 62.0%; and for patients with the absence of response, it was 32.7%. There were significant differences in local recurrence-free survival and laryngeal dysfunction-free survival according to the response to induction chemotherapy (P = 0.0001) at the expense of patients with absence of response to induction chemotherapy. Patients with partial response greater than 50% treated with radiotherapy had a tendency to have worse local recurrence-free survival and laryngeal dysfunction-free survival than patients with complete response, but the differences did not reach statistical significance. Patients with the absence of response after induction chemotherapy had significant differences in disease-specific survival according to the second treatment: for patients treated with surgery it was 70.2%, whereas for patients treated with radiotherapy, it was 28.2% (P = 0.0001). In patients with the absence of response to induction chemotherapy, conservative treatment with radiotherapy implies a significant decrease in survival.
Literature
1.
go back to reference The Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685–1690.CrossRef The Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685–1690.CrossRef
2.
go back to reference de Andrés L, Brunet J, López-Pousa A, Burgués J, Quer M, León X, Guedea F, Vega M, Mesía R, López JJ (1995) Function preservation in stage III squamous laryngeal carcinoma: results with an induction chemotherapy protocol. Laryngoscope 105:822–826CrossRefPubMed de Andrés L, Brunet J, López-Pousa A, Burgués J, Quer M, León X, Guedea F, Vega M, Mesía R, López JJ (1995) Function preservation in stage III squamous laryngeal carcinoma: results with an induction chemotherapy protocol. Laryngoscope 105:822–826CrossRefPubMed
3.
go back to reference Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890–899CrossRefPubMed Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890–899CrossRefPubMed
4.
go back to reference Richard JM, Sancho-Garnier H, Pessey JJ, Luboinski B, Lefebvre JL, Dehesdin D, Stromboni-Luboinski M, Hill C (1998) Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol 34:224–228CrossRefPubMed Richard JM, Sancho-Garnier H, Pessey JJ, Luboinski B, Lefebvre JL, Dehesdin D, Stromboni-Luboinski M, Hill C (1998) Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol 34:224–228CrossRefPubMed
5.
go back to reference Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098CrossRefPubMed Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098CrossRefPubMed
6.
go back to reference Urba S, Wolf G, Eisbruch A, Worden F, Lee J, Bradford C, Teknos T, Chepeha D, Prince M, Hogikyan N, Taylor J (2006) Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. J Clin Oncol 24:593–598CrossRefPubMed Urba S, Wolf G, Eisbruch A, Worden F, Lee J, Bradford C, Teknos T, Chepeha D, Prince M, Hogikyan N, Taylor J (2006) Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. J Clin Oncol 24:593–598CrossRefPubMed
7.
go back to reference Majem M, Mesia R, Mañós M, Gomez J, Galiana R, Cardenal F, Juan A, Montes A, Perez FJ, Nogues J, Llluch JR (2006) Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d’Oncologia in stage III larynx carcinoma. Laryngoscope 116:1651–1656CrossRefPubMed Majem M, Mesia R, Mañós M, Gomez J, Galiana R, Cardenal F, Juan A, Montes A, Perez FJ, Nogues J, Llluch JR (2006) Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d’Oncologia in stage III larynx carcinoma. Laryngoscope 116:1651–1656CrossRefPubMed
8.
go back to reference Lefebvre JL, Rolland F, Tesselaar M et al (2009) Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst 101:142–152CrossRefPubMedPubMedCentral Lefebvre JL, Rolland F, Tesselaar M et al (2009) Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst 101:142–152CrossRefPubMedPubMedCentral
9.
go back to reference Pointreau Y, Garaud P, Chapet S et al (2009) Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 101:498–506CrossRefPubMed Pointreau Y, Garaud P, Chapet S et al (2009) Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 101:498–506CrossRefPubMed
10.
go back to reference Lefebvre JL, Pointreau Y, Rolland F et al (2013) Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study. J Clin Oncol 31:853–859CrossRefPubMed Lefebvre JL, Pointreau Y, Rolland F et al (2013) Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study. J Clin Oncol 31:853–859CrossRefPubMed
11.
go back to reference Gorphe P, Matias M, Blanchard P, Even C, Ferte C, Tao Y, Temam S, Bidault F, Janot F (2016) Outcomes following laryngectomy refusal after insufficient response to induction chemotherapy. Laryngoscope/bib [Epub ahead of print]. Gorphe P, Matias M, Blanchard P, Even C, Ferte C, Tao Y, Temam S, Bidault F, Janot F (2016) Outcomes following laryngectomy refusal after insufficient response to induction chemotherapy. Laryngoscope/bib [Epub ahead of print].
12.
go back to reference León X, López-Pousa A, de Vega M, Orús C, de Juan M, Quer M (2005) Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced laryngeal carcinoma. Eur Arch Otorhinolaryngol 262:93–98CrossRefPubMed León X, López-Pousa A, de Vega M, Orús C, de Juan M, Quer M (2005) Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced laryngeal carcinoma. Eur Arch Otorhinolaryngol 262:93–98CrossRefPubMed
13.
go back to reference León X, Orús C, Quer M (2002) Diseño, mantenimiento y explotación de una base de datos oncológica para pacientes con tumores malignos de cabeza y cuello. Acta Otorrinolaringol Esp 53:185–190CrossRefPubMed León X, Orús C, Quer M (2002) Diseño, mantenimiento y explotación de una base de datos oncológica para pacientes con tumores malignos de cabeza y cuello. Acta Otorrinolaringol Esp 53:185–190CrossRefPubMed
14.
go back to reference Lefebvre JL, Ang KK (2009) Larynx Preservation Consensus Panel. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary. Head Neck 31:429–441CrossRefPubMed Lefebvre JL, Ang KK (2009) Larynx Preservation Consensus Panel. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary. Head Neck 31:429–441CrossRefPubMed
Metadata
Title
Relationship between response to induction chemotherapy and disease control in patients with advanced laryngeal carcinoma included in an organ preservation protocol
Authors
Xavier León
Cristina Valero
Carlota Rovira
Camilo Rodriguez
Montserrat López
Jacinto García-Lorenzo
Miquel Quer
Publication date
01-06-2017
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Oto-Rhino-Laryngology / Issue 6/2017
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-017-4548-1

Other articles of this Issue 6/2017

European Archives of Oto-Rhino-Laryngology 6/2017 Go to the issue